The Effectiveness of Antibacterial Therapeutic Clothing Based on Silver or Chitosan as Compared With Non-antibacterial Therapeutic Clothing in Patients With Moderate to Severe Atopic Dermatitis
NCT04297215 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165
Last updated 2020-07-22
Summary
Since 2000 therapeutic clothing or functional textiles based on silver or chitosan as antibacterial agents were introduced as therapeutics of atopic dermatitis (AD). These agents aim to reduce skin colonization with Staphylococcus (S.) aureus. S. aureus induces further dysregulation of the inflammatory process and increased colonization with S. aureus is correlated with increased AD severity. Based on the theoretical mode of action and clinical experience, we assume a higher effectiveness of antimicrobial therapeutic clothing compared to control therapeutic clothing on reducing AD severity. The goal of this study is to assess the effectiveness of antibacterial clothing based on silver or chitosan on the doctor-reported AD severity in patients with moderate to severe AD. Secondary goals are to retrieve information about the effect of antimicrobial clothing on clinical symptoms, quality of life, S. aureus colonization, AD medication use and the satisfaction regarding the clothing.
Conditions
Interventions
- DEVICE
-
DermaCura® Chitosan based antimicrobial therapeutic clothing
DermaCura® antimicrobial therapeutic clothing (D\&M) consists of 98% TENCEL® and 2% elastane. 1% chitosan has been added to TENCEL® The therapeutic clothing is to be worn at night during the 12-month intervention period and if needed during the day. Usual care including application of emollients, corticosteroid ointments or creams only if needed and/or antihistamines is continued, with standardized steroid ointments and treatment regimens for comparability purposes.
- DEVICE
-
Binamed® silver based antimicrobial therapeutic clothing
The Binamed® antimicrobial therapeutic clothing (BAP Medical) consists of micro-modal, lycra and woven silver filaments as antibacterial agent. The therapeutic clothing is to be worn at night during the 12-month intervention period and if needed during the day. Usual care including application of emollients, corticosteroid ointments or creams only if needed and/or antihistamines is continued, with standardized steroid ointments and treatment regimens for comparability purposes.
- DEVICE
-
Binamed® therapeutic clothing without antimicrobial agents
The Binamed® therapeutic clothing without antimicriobial agents (BAP Medical) is therapeutic clothing made of micro-modal and lycra. Micro-madal is a semi-synthetic wood cellulose fiber. This fiber has a high strength hand elasticity, a high moisture-permeability and feels soft. Lycra ensures an optimal fit on the skin. The therapeutic clothing is to be worn at night during the 12-month intervention period and if needed during the day. Usual care including application of emollients, corticosteroid ointments or creams only if needed and/or antihistamines is continued, with standardized steroid ointments and treatment regimens for comparability purposes.
Sponsors & Collaborators
-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
collaborator OTHER -
UMC Utrecht
collaborator OTHER -
St. Antonius Hospital
collaborator OTHER -
ZonMw: The Netherlands Organisation for Health Research and Development
collaborator OTHER -
BAP Medical
collaborator UNKNOWN -
D&M B.V.
collaborator UNKNOWN -
DeclaCare
collaborator UNKNOWN -
University Medical Center Groningen
collaborator OTHER - lead OTHER
Principal Investigators
-
Suzanne G.M.A Pasmans, Prof · Erasmus MC University Medical Center Rotterdam Dept Dermatology, Center of Paedatric Dermatology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-17
- Primary Completion
- 2022-10-01
- Completion
- 2023-01-01
Countries
- Netherlands
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
NCT07037901 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
NCT02757729 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis
NCT01808157 ·Status: COMPLETED ·Phase: PHASE2
-
DMT210 Topical Gel in the Treatment of Atopic Dermatitis
NCT02949960 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
NCT01232985 ·Status: COMPLETED ·Phase: PHASE2
-
Study of TDM-180935 in Atopic Dermatitis Patients
NCT06363461 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema
NCT02224950 ·Status: WITHDRAWN ·Phase: NA
-
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
NCT07259343 ·Status: RECRUITING ·Phase: NA
-
Soothing and Barrier Restoration Activity of a Body Cream for Atopic Skin
NCT03484897 ·Status: COMPLETED ·Phase: NA
-
Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema
NCT02691507 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis
NCT04307862 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating the Effect of Bathing Additives in Atopic Dermatitis
NCT04001855 ·Status: TERMINATED ·Phase: NA
-
Evaluating Results of Regularly Applied Emollient - Spray in Atopic Dermatitis Therapy
NCT02763722 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients
NCT01714245 ·Status: COMPLETED
-
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
NCT03461302 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
NCT03345914 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis
NCT05984420 ·Status: RECRUITING ·Phase: NA
-
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NCT06756438 ·Status: RECRUITING ·Phase: NA
-
Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis
NCT00148746 ·Status: COMPLETED ·Phase: NA
-
Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)
NCT00076375 ·Status: COMPLETED ·Phase: PHASE2
-
CT 327 in the Treatment of Atopic Dermatitis
NCT00996008 ·Status: TERMINATED ·Phase: PHASE2
-
Targeted Microbiome Transplant in Atopic Dermatitis
NCT03151148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
KM110329 in Adult Patients With Atopic Dermatitis
NCT01692093 ·Status: UNKNOWN ·Phase: PHASE2
-
Short-term Topical Application to Prevent Atopic Dermatitis
NCT03871998 ·Status: COMPLETED ·Phase: NA
-
Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis
NCT06509243 ·Status: COMPLETED ·Phase: NA